The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
Abstract
OBJECTIVES: The goal of this study was to examine rates of psychotropic medication use and identify associated child and family characteristics among children and adolescents with autism spectrum disorder (ASD) enrolled in an autism registry maintained by the Autism Treatment Network (ATN). METHODS: The sample, derived from the ATN registry, consists of 2853 children aged 2 to 17 years with diagnoses of ASD supported by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the Autism Diagnostic Observation Schedule with available data on medication use. As part of initial enrollment in the registry, parents completed questionnaires on current psychotropic medication use, psychiatric and medical conditions, and demographics. RESULTS: Of the 2853 children, 763 (27%) were taking ≥ 1 psychotropic medication; 15% were prescribed 1 medication, 7.4% received 2 medications, and 4.5% received ≥ 3. Among children aged 3 to 5 years, 11% were taking ≥ 1 psychotropic medication; among 6- to 11-year-old children, 46%; and 66% of adolescents aged 12 to 17 years were taking at ≥ 1 psychotropic medication. A parent report of comorbid diagnosis of attention-deficit/hyperactivity disorder, bipolar disorder, obsessive-compulsive disorder, depression, or anxiety was associated with a high rate of use, with 80% receiving ≥ 1 psychotropic medication. Only 15% of children with no comorbid psychiatric disorder were taking psychotropic medication. Psychotropic medication use was also related to sleep and gastrointestinal problems. CONCLUSIONS: The prescription of psychotropic medications in this registry sample is highly related to comorbid psychiatric disorder. Other factors associated with use include medical comorbidities, race, ethnicity, and older age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have reported high rates of polypharmacy ranging from 12 to 35% based on the type of studies [28, 29].”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [28]
Citations
Cites
Owens, J. A., Spirito, A., & McGuinn, M. (2000) · Sleep · doi:10.1093/sleep/23.8.1d · Cited by 2,535
Buie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872
Self-citationAchenbach, T. M. (2000) · American Psychological Association eBooks · doi:10.1037/10517-028 · Cited by 572
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Self-citationMcDougle, C. J., Scahill, L. D., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., Arnold, L. E., Posey, D. J., Martin, A., GHUMAN, J. K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1142 · Cited by 477
Sleep problems as possible predictors of intensified symptoms of autism*1
Schreck, K. A. (2003) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2003.04.007 · Cited by 419
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415
The Children's Sleep Habits Questionnaire in Toddlers and Preschool Children
Goodlin‐Jones, B. L., Sitnick, S. L., Tang, K. L., Liu, J., & Anders, T. F. (2008) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318163c39a · Cited by 362
Sleep Deprivation Impairs the Accurate Recognition of Human Emotions
van der Helm, E., Gujar, N., & Walker, M. P. (2010) · SLEEP · doi:10.1093/sleep/33.3.335 · Cited by 336
Flagged first, then by citations
Research works printed but not linked: 1
- McDougle, 2008, Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders, J Clin Psychiatry., 69, 15
Cited by
Sorted by citations
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
The prevalence of parent-reported autism spectrum disorder among US children
Kogan, M. D., Vladutiu, C. J., Schieve, L. A., Ghandour, R. M., Blumberg, S. J., Zablotsky, B., Perrin, J. M., Shattuck, P., Kuhlthau, K. A., Harwood, R. L., et al. (2018) · Pediatrics · doi:10.1542/peds.2017-4161 · Cited by 354
Self-citationHowes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117741766 · Cited by 342
The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential
Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_17 · Cited by 329
Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder
Buck, T. R., Viskochil, J., Farley, M., Coon, H., McMahon, W. M., Morgan, J., & Bilder, D. A. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2170-2 · Cited by 323
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
An update on the comorbidity of ADHD and ASD: a focus on clinical management
Antshel, K. M., Zhang‐James, Y., Wagner, K. E., Ledesma, A., & Faraone, S. V. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1146591 · Cited by 276
Hill, A. P., Zuckerman, K. E., & Fombonne, E. J. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1437 · Cited by 256
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01183-1 · Cited by 233
Guastella, A. J., & Hickie, I. B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.028 · Cited by 223
An update on pharmacotherapy for autism spectrum disorder in children and adolescents
Ji, N. Y., & Findling, R. L. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000132 · Cited by 217
Psychotropic medication use and polypharmacy in children with autism spectrum disorders
Spencer, D., Marshall, J., Post, B., Kulakodlu, M., Newschaffer, C., Dennen, T., Azocar, F., & Jain, A. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3774 · Cited by 215
Autism Spectrum Disorder: Defining Dimensions and Subgroups
Ousley, O., & Cermak, T. (2013) · Current Developmental Disorders Reports · doi:10.1007/s40474-013-0003-1 · Cited by 229
Chen, M., Lan, W.-H., Hsu, J.-W., Huang, K., Su, T., Li, C., Lin, W.-C., Tsai, C.-F., Tsai, S., Lee, Y.-C., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1807 · Cited by 175
Handen, B. L., Aman, M. G., Arnold, L. E., Hyman, S. L., Tumuluru, R. V., Lecavalier, L., Corbett-Dick, P., Pan, X., Hollway, J. A., Buchan-Page, K. A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.013 · Cited by 147
Risk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder
Dhaliwal, K. K., Orsso, C. E., Richard, C., Haqq, A. M., & Zwaigenbaum, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133285 · Cited by 157
Psychopharmacological interventions in autism spectrum disorder
Accordino, R. E., Kidd, C. L., Politte, L. C., Henry, C. A., & McDougle, C. J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1154536 · Cited by 128
Houghton, R., Ong, R. C., & Bolognani, F. (2017) · Autism Research · doi:10.1002/aur.1848 · Cited by 124
Neuhaus, E., Bernier, R., & Beauchaine, T. P. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1923-7 · Cited by 119
Fallah, M. S., Shaikh, M. R., Neupane, B., Rusiecki, D. R., Bennett, T. A., & Beyene, J. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0115 · Cited by 116
Chandrasekhar, T., & Sikich, L. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.2/tchandrasekhar · Cited by 126
Gordon, I., Jack, A., Pretzsch, C. M., Vander Wyk, B., Leckman, J. F., Feldman, R., & Pelphrey, K. A. (2016) · Scientific Reports · doi:10.1038/srep35054 · Cited by 114
Services for children with autism in the Kingdom of Saudi Arabia
Alnemary, F. M., Aldhalaan, H., Simon‐Cereijido, G., & Alnemary, F. (2016) · Autism · doi:10.1177/1362361316664868 · Cited by 107
Branford, D. M. L., Gerrard, D., Saleem, N., Shaw, C., & Webster, A. (2018) · Advances in Mental Health and Intellectual Disabilities · doi:10.1108/amhid-02-2018-0004 · Cited by 96
Insular function in autism: Update and future directions in neuroimaging and interventions
Nomi, J. S., Molnar-Szakacs, I., & Uddin, L. Q. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.015 · Cited by 98
Aman, M. G., Rettiganti, M. R., Nagaraja, H. N., Hollway, J. A., McCracken, J. T., McDougle, C. J., Tierney, E., Scahill, L. D., Arnold, L. E., Hellings, J. A., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0005 · Cited by 90
Hsia, Y., Wong, A. Y. S., Murphy, D., Simonoff, E. A., Buitelaar, J. K., & Wong, I. C. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3263-x · Cited by 89
Mosner, M. G., Kinard, J. L., Shah, J. S., McWeeny, S., Greene, R. K., Lowery, S., Mazefsky, C. A., & Dichter, G. S. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04090-1 · Cited by 88
Masi, A., Lampit, A., Glozier, N., Hickie, I. B., & Guastella, A. J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.143 · Cited by 78
Anxiety moderates the influence of ASD severity on quality of life in adults with ASD
Smith, I. C., Ollendick, T. H., & White, S. W. (2019) · Research in Autism · doi:10.1016/j.rasd.2019.03.001 · Cited by 73
Feroe, A. G., Uppal, N., Gutiérrez-Sacristán, A., Mousavi, S., Greenspun, P., Surati, R., Kohane, I. S., & Avillach, P. (2021) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.1329 · Cited by 72
Mental Health Services for Individuals with High Functioning Autism Spectrum Disorder
Lake, J. K., Perry, A., & Lunsky, Y. (2014) · Autism Research and Treatment · doi:10.1155/2014/502420 · Cited by 72
Mandić-Maravić, V., Grujičić, R., Milutinovic, L., Munjiza, A., & Pejovic-Milovancevic, M. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.787097 · Cited by 75
Psychopharmacological Interventions in Autism Spectrum Disorder
Politte, L. C., Henry, C. A., & McDougle, C. J. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000030 · Cited by 75
Comorbid Psychopathology in Autism Spectrum Disorder
Mannion, A., Brahm, M., & Leader, G. (2014) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-014-0012-y · Cited by 77
Bachmann, C. J., Manthey, T., Kamp-Becker, I., Glaeske, G., & Hoffmann, F. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2013.05.028 · Cited by 63
Systematic review and guide to management of core and psychiatric symptoms in youth with autism
Ameis, S. H., Kassee, C., Corbett-Dick, P., Cole, L. L., Dadhwal, S., Lai, M., Veenstra-VanderWeele, J. M., & Correll, C. U. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12918 · Cited by 64
Self-citationDowns, J. M., Hotopf, M. H., Ford, T. J., Simonoff, E. A., Jackson, R., Shetty, H., Stewart, R. J., & Hayes, R. D. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0780-7 · Cited by 59
Planning Skills in Autism Spectrum Disorder Across the Lifespan: A Meta-analysis and Meta-regression
Dubbelink, L. O., & Geurts, H. M. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-3013-0 · Cited by 67
Handen, B. L., Anagnostou, E. A., Aman, M. G., Sanders, K. B., Chan, J. G. M., Hollway, J. A., Brian, J. A., Arnold, L. E., Capano, L., Williams, C. E., et al. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.07.790 · Cited by 57
Self-citationMcCormick, C. E. B., Kavanaugh, B. C., Sipsock, D., Righi, G., Oberman, L. M., Moreno‐De‐Luca, D., Uzun, E. D. G., Best, C. R., Jerskey, B. A., Quinn, J. G., et al. (2020) · Autism Research · doi:10.1002/aur.2261 · Cited by 52
Relations between Sensory Responsiveness and Features of Autism in Children
Feldman, J. I., Cassidy, M. M., Liu, Y., Kirby, A. V., Wallace, M. T., & Woynaroski, T. G. (2020) · Brain Sciences · doi:10.3390/brainsci10110775 · Cited by 57
Lamberti, M., Siracusano, R., Italiano, D., Alosi, N., Cucinotta, F., Rosa, G. D., Germanò, E., Spina, E., & Gagliano, A. (2016) · Pediatric Drugs · doi:10.1007/s40272-016-0183-3 · Cited by 51
Autism Spectrum Disorder and Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis
Vaquerizo‐Serrano, J., de Pablo, G. S., Singh, J., & Santosh, P. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05046-0 · Cited by 59
Deb, S. S., Roy, M., Lee, R., Majid, M., Limbu, B., Santambrogio, J., Roy, A., & Bertelli, M. O. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1003 · Cited by 60
An Update on Medication Management of Behavioral Disorders in Autism
Baribeau, D. A., & Anagnostou, E. A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0437-0 · Cited by 52
Self-citationAge-related trends in treatment use for children with autism spectrum disorder
Mire, S. S., Raff, N. S., Brewton, C. M., & Goin‐Kochel, R. P. (2015) · Research in Autism · doi:10.1016/j.rasd.2015.03.001 · Cited by 49
Iffland, M., Livingstone, N., Jorgensen, M. L., Hazell, P., & Gillies, D. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011769.pub2 · Cited by 58
Ezell, J. A., Hogan, A. L., Fairchild, A. J., Hills, K. J., Klusek, J., Abbeduto, L., & Roberts, J. E. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3804-6 · Cited by 54
Polypharmacy in pediatric patients and opportunities for pharmacists' involvement
Horace, A. E., & Ahmed, F. (2015) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s64535 · Cited by 47
Evidence-Based Treatments for Autism Spectrum Disorder
Politte, L. C., Howe, Y. J., Nowinski, L. A., Palumbo, M., & McDougle, C. J. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0031-z · Cited by 54
Obsessions, Compulsions, and Repetitive Behavior: Autism and/or OCD
Wu, M. S., Rudy, B. M., & Storch, E. A. (2014) · Autism and Child Psychopathology Series · doi:10.1007/978-3-319-06796-4_8 · Cited by 43
Vohra, R., Madhavan, S., Sambamoorthi, U., StPeter, C., Poe, S. G., Dwibedi, N., & Ajmera, M. (2016) · Drugs - Real World Outcomes · doi:10.1007/s40801-016-0096-z · Cited by 44
Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review
Ritter, C., Hewitt, K., & McMorris, C. A. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0110 · Cited by 40
Adams, H. L., Matson, J. L., & Jang, J. (2014) · Research in Autism · doi:10.1016/j.rasd.2014.05.008 · Cited by 39
RetractedComorbid Behavioral Problems and Psychiatric Disorders in Autism Spectrum Disorders
Belardinelli, C., & Raza, M. (2016) · Journal of Childhood & Developmental Disorders · doi:10.4172/2472-1786.100019 · Cited by 49
Deb, S. S., Roy, M., & Limbu, B. (2022) · BJPsych Advances · doi:10.1192/bja.2022.61 · Cited by 38
Moving From Research to Practice in the Primary Care of Children With Autism Spectrum Disorders
Carbone, P. S. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.04.003 · Cited by 33
Deb, S. S., Roy, M., Limbu, B., Brizard, B. A., M.Murugan, M. P. A., Roy, A., & Santambrogio, J. (2023) · Psychological Medicine · doi:10.1017/s003329172300212x · Cited by 32
Wong, A. Y. S., Hsia, Y., Chan, E. W., Murphy, D., Simonoff, E. A., Buitelaar, J. K., & Wong, I. C. K. (2014) · Autism Research · doi:10.1002/aur.1391 · Cited by 31
The Autism Speaks Autism Treatment Network Registry Data: Opportunities for Investigators
Murray, D. S., Fedele, A., Shui, A. M., & Coury, D. L. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2851e · Cited by 32
Self-citationCvejic, R. C., Arnold, S. R. C., Foley, K., & Trollor, J. N. (2018) · BJPsych Open · doi:10.1192/bjo.2018.64 · Cited by 30
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid
Rast, J. E., Tao, S., Schott, W., Shea, L., Brodkin, E. S., Kerns, C. M., Leonard, C. E., Murray, M. J., & Lee, B. K. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06182-5 · Cited by 29
Psychotropic medications for highly vulnerable children
McLaren, J., Barnett, E. R., Concepción-Zayas, M. T., Lichtenstein, J. D., Acquilano, S. C., Schwartz, L. M., Woloshin, S., & Drake, R. E. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1445720 · Cited by 29
Psychopharmacologic Management of Serious Behavioral Disturbance in ASD
Stigler, K. A. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.07.005 · Cited by 28
Weight management interventions for youth with autism spectrum disorder: a systematic review
Healy, S., Pacanowski, C. R., & Williams, E. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0233-8 · Cited by 26
Methylphenidate in Autism Spectrum Disorder: A Long-Term Follow Up Naturalistic Study
Ventura, P., de Giambattista, C., Spagnoletta, L., Trerotoli, P., Cavone, M., Gioia, A. D., & Margari, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082566 · Cited by 26
Moyal, W. N., Lord, C., & Walkup, J. T. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0050-4 · Cited by 26
Assessment of Autism Across the Lifespan: A Way Forward
Klaiman, C., Fernàndez‐Carriba, S., Hall, C., & Saulnier, C. A. (2014) · Current Developmental Disorders Reports · doi:10.1007/s40474-014-0031-5 · Cited by 27
Rasmussen, L., Bilenberg, N., Ernst, M., Boysen, S. A., & Pottegård, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100339 · Cited by 25
Limbu, B., Deb, S. S., Roy, M., Lee, R., Roy, A., & Taiwo, O. (2022) · BJPsych Open · doi:10.1192/bjo.2022.18 · Cited by 23
Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
Aishworiya, R., Protic, D. D., Tang, S. J., Schneider, A., Tassone, F., & Hagerman, R. J. (2022) · Genes · doi:10.3390/genes13122399 · Cited by 21
Logan, S. L., Carpenter, L. A., Leslie, R. S., Hunt, K. S., Garrett-Mayer, E. S., Charles, J. M., & Nicholas, J. S. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2156-0 · Cited by 24
Araripe, B., Montiel‐Nava, C., Bordini, D., da Cunha, G. R., Garrido, G., Cukier, S., Garcia, R., Rosoli, A., Valdez, D., Caetano, S. C., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12101421 · Cited by 24
Carey, M., Sheehan, D., Healy, S., Knott, F. J., & Kinsella, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095471 · Cited by 27
Perrin, J. M., Coury, D. L., Klatka, K., Winklosky, B., Wolfe, A. E., Murray, D. S., & Kuhlthau, K. A. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2851d · Cited by 22
Self-citationScahill, L. D., & Challa, S. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-29695-1_3 · Cited by 22
Lake, J., Denton, D., Lunsky, Y., Shui, A., Veenstra-VanderWeele, J., & Anagnostou, E. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3058-8 · Cited by 23
Self-citationHollway, J. A., Mendoza-Burcham, M., Andridge, R., Aman, M. G., Handen, B. L., Arnold, L. E., Lecavalier, L., Williams, C. E., Silverman, L. B., & Smith, T. H. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0085 · Cited by 23
Therapy and Psychotropic Medication Use in Young Children With Autism Spectrum Disorder
Ziskind, D., Bennett, A. E., Jawad, A. F., & Blum, N. J. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1895m · Cited by 22
Lake, J. K., Weiss, J. A., Dergal, J. M., & Lunsky, Y. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0011 · Cited by 21
Dinnissen, M., Dietrich, A., van den Hoofdakker, B. J., & Hoekstra, P. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.981151 · Cited by 21
House, S. A., Goodman, D. C., Weinstein, S. J., Chang, C., Wasserman, J. R., & Morden, N. E. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.027 · Cited by 21
Psychotropic Use Among Youths With Intellectual and Developmental Disabilities
McLaren, J., Lichtenstein, J. D., Metcalfe, J. D., Charlot, L., Drake, R. E., & Beasley, J. B. (2021) · Psychiatric Services · doi:10.1176/appi.ps.201900465 · Cited by 21
Pemovska, T., Loizou, S., Appleton, R., Spain, D., Stefanidou, T., Kular, A., Cooper, R. E., Greenburgh, A., Griffiths, J., Barnett, P., et al. (2024) · Psychological Medicine · doi:10.1017/s0033291724001089 · Cited by 23
Rizzo, R., & Pavone, P. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1211007 · Cited by 21
Pearson, D. A., Santos, C. W., Aman, M. G., Arnold, L. E., Lane, D. M., Loveland, K. A., Mansour, R., Ward, A. R., Casat, C. D., Jerger, S. W., et al. (2020) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0004 · Cited by 20
Quebles, I., Solomon, O., Smith, K. A., Rao, S. R., Lu, F., Azen, C. G., Anaya, G., & Yin, L. (2020) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-125.5.369 · Cited by 20
Potential natural products for the management of autism spectrum disorder
Sachdeva, P., Mehdi, I., Kaith, R., Ahmad, F., & Anwar, M. S. (2022) · Ibrain · doi:10.1002/ibra.12050 · Cited by 18
Bird, F. L., Harper, J. M., Luiselli, J. K., Shlesinger, A., & Gold, J. (2022) · Behavior Analysis in Practice · doi:10.1007/s40617-022-00699-4 · Cited by 17
Friedman, N. D. B., Politte, L. C., Nowinski, L. A., & McDougle, C. J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch44 · Cited by 17
Bose‐Brill, S., Xing, J., Barnette, D. J., & Hanks, C. D. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s130247 · Cited by 15
Barrie, E. S., Pinsonneault, J. K., Sadée, W., Hollway, J. A., Handen, B. L., Smith, T. H., Arnold, L. E., Butter, E. M., Hansen‐Kiss, E., Herman, G. E., et al. (2018) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-018-9590-4 · Cited by 16
O’Brien, M. J., Pauls, A. M., Cates, A. M., Larson, P. D., & Zorn, A. N. (2024) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2024.114056 · Cited by 15
Lake, J. K., Vogan, V. M., Sawyer, A., Weiss, J. A., & Lunsky, Y. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0106 · Cited by 15
Johnson, N. L., Burkett, K., Reinhold, J., & Bultas, M. W. (2015) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2015.09.008 · Cited by 23
Coury, D. L., Swedo, S. E., Thurm, A. E., Miller, D. T., Veenstra-VanderWeele, J. M., Carbone, P. S., & Taylor, J. L. (2014) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2013.12.002 · Cited by 16
Self-citationMoharreri, F., Abdollahian, E., Hosseini, S. A., & Mirzadeh, M. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22038/ijp.2017.18557.1516 · Cited by 14
Managing anxiety comorbidity in youth with autism spectrum disorders
Rudy, B. M., Lewin, A. B., & Storch, E. A. (2013) · Neuropsychiatry · doi:10.2217/npy.13.53 · Cited by 16
Shurtz, L., Schwartz, C., DiStefano, C., McPartland, J. C., Levin, A. R., Dawson, G., Kleinhans, N. M., Faja, S., Webb, S. J., Shic, F., et al. (2022) · Autism · doi:10.1177/13623613221121425 · Cited by 13
Metadata
- Authors
- Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M.
- Affiliations
- Nationwide Children's Hospital (US)
- University of Toronto (CA)
- Department of Pediatrics, University of Cincinnati College of Medicine, and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
- University of Colorado Denver (US)
- University of Rochester Medicine (US)
- Oregon Health & Science University (US)
- Columbia University (US)
- Harvard University (US)
- Corresponding author
- Coury, Daniel L.
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2012-11-01
- Volume
- 130
- Issue
- Supplement_2
- Pages
- S69-S76
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2134810756
- Cited by
- 191
- References
- 32
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 15 · 2023: 7 · 2022: 20 · 2021: 13 · 2020: 14 · 2019: 11 · 2018: 16 · 2017: 15 · 2016: 17 · 2015: 19 · 2014: 18 · 2013: 11
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- psychotropic drugs, autism spectrum disorder, children and adolescents, psychiatric comorbidity, attention deficit hyperactivity disorder, bipolar disorder, obsessive-compulsive disorder, depression, anxiety, sleep disorders, gastrointestinal problems
- MeSH terms
- Adolescent, Child, Child Development Disorders, Pervasive, Child, Preschool, Female, Humans, Male, Psychotropic Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
